Get the Stockscreener App
1.58
1.28%
0.02
After Hours:
1.55
-0.03
-1.90%
Longeveron Inc stock is traded at $1.58, with a volume of 104.36K.
It is up +1.28% in the last 24 hours and up +19.70% over the past month.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
See More
Previous Close:
$1.56
Open:
$1.57
24h Volume:
104.36K
Relative Volume:
0.31
Market Cap:
$21.37M
Revenue:
$1.89M
Net Income/Loss:
$-17.92M
P/E Ratio:
-0.2362
EPS:
-6.69
Net Cash Flow:
$-15.62M
1W Performance:
-9.20%
1M Performance:
+19.70%
6M Performance:
-1.25%
1Y Performance:
-51.68%
1-Day Range:
$1.54
$1.63
1-Week Range:
$1.54
$1.76
52-Week Range:
$1.14
$3.35
Longeveron Inc Stock (LGVN) Company Profile
Name
Longeveron Inc
Sector
Industry
Phone
305-302-7158
Address
1951 NW 7TH AVENUE, MIAMI
Compare LGVN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LGVN
Longeveron Inc
|
1.58 | 23.41M | 1.89M | -17.92M | -15.62M | -6.69 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.16 | 120.29B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
554.58 | 60.26B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
339.80 | 43.10B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
598.89 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.94 | 33.09B | 3.81B | -644.79M | -669.77M | -6.24 |
Longeveron Inc Stock (LGVN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-06-24 | Initiated | ROTH MKM | Buy |
Longeveron Inc Stock (LGVN) Latest News
Longeveron Inc. recovery potential after sell offEarly Buy Opportunity with Chart Triggers - Newser
Is now a turning point for Longeveron Inc.Buy Signal Forecast With Short-Term Data - Newser
Buy Signal for Longeveron Inc. Stock Key Technical Indicators to WatchFree Oversold Recovery Opportunity Stocks - Newser
Short interest data insights for Longeveron Inc.Daily Stock Movement Forecast with Accuracy - Newser
Quantitative breakdown of Longeveron Inc. recent moveDeep Learning Stock Forecast for Investors - Newser
What makes Longeveron Inc. stock price move sharplyOptimized Watchlist With Daily Adjustments Launched - metal.it
Why Longeveron Inc. stock attracts strong analyst attentionChart Pattern Strategy with ROI Focus - Newser
Real time pattern detection on Longeveron Inc. stockAutomated AI Forecast with Trading Alerts - Newser
New Product Launches: Will They Boost Longeveron Inc. Stock in 2025Free Daily Chart Pattern Stock Forecast - Newser
Intraday pattern recognizer results for Longeveron Inc.Free Short Term Buy List With Stop Protection - Newser
Automated trading signals detected on Longeveron Inc.High Yield Watchlist with Filtered Picks - Newser
Fibonacci Support Holding Strong in Longeveron Inc.Short Term Buy Zone Stock Alerts Signal Entry - metal.it
How does Longeveron Inc. generate profit in a changing economyBest Dividend Entry Points For Every Investor - jammulinksnews.com
Is Longeveron Inc. a Top Dividend Stock to Watch in 2025Smart Entry Watchlist with Daily Analysis - Newser
Longeveron® Announces Licensing of New Cardiac Selective iPSC Technology for Cardiovascular Disease - BioInformant
Is it the right time to buy Longeveron Inc. stockBuild a balanced portfolio for long-term success - jammulinksnews.com
What catalysts could drive Longeveron Inc. stock higher in 2025Build wealth steadily with proven methods - jammulinksnews.com
What analysts say about Longeveron Inc. stockDynamic growth stocks - PrintWeekIndia
Is Longeveron Inc. a good long term investmentFree High-Return Strategy Alerts - PrintWeekIndia
What risks could impact Longeveron Inc. stock performanceMarket-leading capital gains - jammulinksnews.com
Longeveron Inc. Stock Analysis and ForecastFree Wealth Management Insights - Autocar Professional
How Longeveron Inc. stock performs during market volatilityIntraday Trade Ideas - Newser
What drives Longeveron Inc. stock priceHigh-impact investment strategies - jammulinksnews.com
Published on: 2025-07-22 07:30:15 - Autocar Professional
Longeveron licenses patent for stem cell technology from University of Miami - TipRanks
Longeveron licenses stem cell patent for heart disease treatment - Investing.com
Longeveron licenses stem cell patent for heart disease treatment By Investing.com - Investing.com India
Longeveron Licenses US Patent for Advanced Cardiomyogenic Cell Technology from University of Miami - Nasdaq
Longeveron® Announces Licensing of New Cardiac Selective Induced Pluripotent Stem Cell Technology for Cardiovascular Disease - The Manila Times
Revolutionary Heart Disease Breakthrough: Longeveron Licenses Safer Cardiac Stem Cell Technology - Stock Titan
Longeveron Inc Stock (LGVN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.23%
0.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):